Preclinical Business Developer - Cer Groupe - Preclinical Integrated Services
CurrentCER is a Belgian CRO offering a preclinical plateform with a large range of non-clinical services like the development and validation of preclinical models on rodents and large animals. Our expertise is dedicated to cell therapy, cancerology, infectiology and immunology (vaccine, allergy, autoimmune diseases, immunotherapy,..) that may involve micro-surgery and humanized models. Our aim is to help our customers to develop safe and effective new medicines and other compounds giving a real difference to people's lives.Our main assets are custom-made solutions, reactivity and flexibility in economic and timely manner, taking advantage of our in-house laboratory assays including immuno-monitoring (FACS, ELISA, multiplex-assays,...), access to imagery and bioassays.Our facilities are divided in two areas, SPF/SOPF experimental animal maintenance facilities and ABSL-2 and ABSL-3 facilities for studies involving Biosafety Level 2 or 3 pathogens.Moreover, we also develop partnerships with biotech and pharmaceuticals companies for providing custom-made murine and human monoclonal antibodies.
